BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15662944)

  • 1. [Proteasome and proteolysis].
    Papapostolou D; Reboud-Ravaux M
    J Soc Biol; 2004; 198(3):263-78. PubMed ID: 15662944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome and its role in the degradation of oxidized proteins.
    Jung T; Grune T
    IUBMB Life; 2008 Nov; 60(11):743-52. PubMed ID: 18636510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of proteasome complexes and ubiquitinated proteins.
    Wang X; Guerrero C; Kaiser P; Huang L
    Expert Rev Proteomics; 2007 Oct; 4(5):649-65. PubMed ID: 17941820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition: mechanism of action.
    DeMartino GN
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteasomal system.
    Jung T; Catalgol B; Grune T
    Mol Aspects Med; 2009 Aug; 30(4):191-296. PubMed ID: 19371762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteasomes: their role in cellular processes].
    Tsimokha AS
    Tsitologiia; 2010; 52(4):277-300. PubMed ID: 20540339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.
    Wang J; Maldonado MA
    Cell Mol Immunol; 2006 Aug; 3(4):255-61. PubMed ID: 16978533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
    Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
    Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine cardiac 26S proteasome: an organelle awaiting exploration.
    Gomes AV; Zong C; Edmondson RD; Berhane BT; Wang GW; Le S; Young G; Zhang J; Vondriska TM; Whitelegge JP; Jones RC; Joshua IG; Thyparambil S; Pantaleon D; Qiao J; Loo J; Ping P
    Ann N Y Acad Sci; 2005 Jun; 1047():197-207. PubMed ID: 16093497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of the proteasome in leukaemia.
    McCloskey SM; McMullin MF; Walker B; Irvine AE
    Hematol Oncol; 2008 Jun; 26(2):73-81. PubMed ID: 18324639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NFkappaB and Ub-proteasome pathway during apoptosis induced by a serum factor is mediated through the upregulation of the 26S proteasome subunits.
    Singh S; Khar A
    Apoptosis; 2006 May; 11(5):845-59. PubMed ID: 16532374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome activation as a novel antiaging strategy.
    Chondrogianni N; Gonos ES
    IUBMB Life; 2008 Oct; 60(10):651-5. PubMed ID: 18506854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the proteasome in ethanol-induced liver pathology.
    Donohue TM; Cederbaum AI; French SW; Barve S; Gao B; Osna NA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1446-59. PubMed ID: 17760783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of proteasome in malignant diseases.
    Moran E; Nencioni A
    J BUON; 2007 Sep; 12 Suppl 1():S95-9. PubMed ID: 17935285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ubiquitin-proteasome system in ageing.
    Löw P
    Gen Comp Endocrinol; 2011 May; 172(1):39-43. PubMed ID: 21324320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 26S proteasome: assembly and function of a destructive machine.
    Gallastegui N; Groll M
    Trends Biochem Sci; 2010 Nov; 35(11):634-42. PubMed ID: 20541423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.